Implementation of Empagliflozin in Patients with Diabetes Mellitus Type 2 and Established Cardiovascular Disease: Estimation of 5-Year Survival and Costs in Sweden

INTRODUCTION: Cardiovascular disease (CVD) affects approximately 30% of patients with diabetes mellitus type 2 (T2D) and leads to increased morbidity, decreased survival and increased healthcare utilization. The aim of this study was to estimate the impact of treating these patients with the sodium–...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Diabetes Ther
Main Authors: Bernfort, Lars, Husberg, Magnus, Wiréhn, Ann-Britt, Rosenqvist, Ulf, Gustavsson, Staffan, Karlsdotter, Kristina, Levin, Lars-Åke
Format: Artigo
Sprog:Inglês
Udgivet: Springer Healthcare 2020
Fag:
Original Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7644727/
https://ncbi.nlm.nih.gov/pubmed/33021700
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-020-00937-4
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker